FOXM1 and cholangiocarcinoma: FOXM1 inhibitors, in combination with 5-FU, reduce colony formation, decrease cancer cell migration, and induce caspase-dependent apoptosis in colon and cholangiocarcinoma cancer cell lines [64,65].